Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors

Reproductive BioMedicine Online

Volumn 22, Issue S1, 2011, Pages S88-S93

  Nakhuda, Gary S ^a   Douglas, Nataki C ^a   Thornton, Melvin H ^a   Guarnaccia, Michael M ^a   Lobo, Rogerio ^a   Sauer, Mark V ^a  

^a Centre for Women's Reproductive Care ^*  (United States)

Author keywords

anti M llerian hormone; donor IVF; in vitro fertilization; M llerian inhibiting substance; oocyte donation; ovarian reserve

Indexed keywords

EID: 84860111573     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/S1472-6483(11)60014-X     Document Type: Article

References (23)

1. K. Barnhart, J. Osheroff We are overinterpreting the predictive value of serum follicle-stimulating hormone levels Fertil. Steril. 72 1999 8 9
2. M.A. Barreto Melo, N. Garrido, C. Alvarez et al. Antrat follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization outcome in an egg donation program Fértil. Steril. 91 2009 148 156
3. M.A. Cohen, S.R. Lindheim, M.V. Sauer Donor age is paramount to success in oocyte donation Hum. Reprod. 14 1999 2755 2758
4. C.L. Cook, Y. Siow, A.G. Brenner, M.E. Fallat Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with poly-cystic ovary syndrome and normal women Fertil. Steril. 77 2002 141 146
5. A. de Vet, J.S. Laven, F.H. de Jong et al. Antimullerian hormone serum levels: a putative marker for ovarian ageing Fertil. Steril. 77 2002 357 362
6. T. Ebner, M. Sommergruber, M. Moser et al. Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles Hum. Reprod. 21 2006 2022 2026
7. M.A. Esposito, C. Coutifaris, K.T. Barnhart A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women Hum. Reprod. 17 2002 118 123
8. B.M. Faber, R. Mercan, P. Hamacher et al. The impact of an egg donor's age and her prior fertility on recipient pregnancy outcome Fertil. Steril. 68 1997 370 372
9. M.E. Fallat, Y. Siow, M. Marra et al. Mullerian-inhibiting substance in follicular fluid and serum: a comparison of patients with tubal factor infertility, polycystic ovary syndrome, and endometriosis Fertil. Steril. 67 1997 962 965
10. C. Ficicioglu, T. Kutlu, E. Baglam, Z. Bakacak Early follicular antimullerian hormone as an indicator of ovarian reserve Fertil. Steril. 85 2006 592 596
11. A. Hazout, P. Bouchard, D.B. Seifer et al. Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or oestradiol Fertil. Steril. 82 2004 1323 1329
12. W.J. Hehenkamp, C.W. Looman, A.P. Themmen et al. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J. Clin. Endocrinol. Metab. 91 2006 4057 4063
13. J. Klein, M.V. Sauer Oocyte donation Best Pract. Res. 16 2002 277 291
14. T.H. Lee, C.H. Liu, C.C. Huang et al. Serum anti-Mullerian hormone and oestradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles Hum. Reprod. 23 2008 160 167
15. G. Letterie, L. Marshall, M. Angle The relationship of clinical response, oocyte number, and success in oocyte donor cycles J. Assist. Reprod. Genet. 22 2005 115 117
16. G.S. Nakhuda, M.C. Chu, J.G. Wang et al. Elevated serum mullerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization Fertil. Steril. 85 2006 1541 1543
17. G.S. Nakhuda, M.V. Sauer, J.G. Wang et al. Mullerian inhibiting substance is an accurate marker of ovarian response in women of advanced reproductive age undergoing IVF Reprod. BioMed. Online 14 2007 450 454
18. S.M. Nelson, R.W. Yates, R. Fleming Serum anti-Mullerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles-implications for individualization of therapy Hum. Reprod. 22 2007 2414 2421
19. D.B. Seifer, D.T. MacLaughlin, B.P. Christian et al. Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil. Steril. 77 2002 468 471
20. T. Silberstein, D.T. MacLaughlin, I. Shai et al. Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology Hum. Reprod. 21 2006 159 163
21. A. Somunkiran, T. Yavuz, O. Yucel, I. Ozdemir Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome Eur. J. Obstet. Gynecol. Reprod. Biol. 134 2007 196 201
22. S. Tsepelidis, F. Devreker, I. Demeestere et al. Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women Hum. Reprod. 22 2007 1837 1840
23. I.A. van Rooij, F.J. Broekmans, E.R. te Velde et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve Hum. Reprod. 17 2002 3065 3071